Epigenetic clocks—molecular measurements that estimate biological age based on DNA methylation patterns—are emerging as tools to detect early aging and identify intervention opportunities in midlife. However, a critical practical question remains: can we use any tissue to measure biological age, or does it matter which tissue we sample? This study directly tackled that question by comparing 15 different DNA methylation clocks across three tissue types in the same individuals.
The researchers collected saliva, buffy coat (white blood cells), and peripheral blood mononuclear cells (PBMCs) from 91 participants (average age 31) enrolled in the Colorado Adoption/Twin Study of Lifespan behavioral development and cognitive aging. The sample included unpaired individuals and sibling/twin pairs, which allowed the team to examine genetic influences on epigenetic aging patterns. They then applied 15 published DNA methylation clocks to measure biological age in each tissue and compared the results.
Key findings: Saliva showed consistently higher DNA methylation ages—about 4–16 years older than buffy coat estimates (p<0.001)—but buffy coat and PBMCs were nearly interchangeable. Interestingly, newer-generation clocks (PCGrimAge and DunedinPace) behaved differently, showing comparable results across tissues. When examining genetic influences via twin pairs, monozygotic (genetically identical) twins showed stronger correlation in blood tissues (r≈0.64) than in saliva (r≈0.33), suggesting that saliva methylation aging may be more influenced by environmental or technical factors.
Important limitations deserve emphasis: This is a preprint with zero citations, meaning peer review is still pending and findings are unverified. The sample is small (N=91, mean age 31), relatively homogeneous (Colorado adoptee/twin cohort, 50% female), and restricted to early-to-mid adulthood, limiting generalizability. The moderate correlations between chronological age and methylation age across all tissues (r≈0.37–0.41) suggest these clocks still explain only ~15% of age variance, raising questions about their predictive utility. The cross-sectional design cannot establish whether tissue-specific aging patterns predict future health outcomes.
For longevity research, this work highlights a crucial methodological issue: tissue choice matters. The findings suggest saliva is not a drop-in replacement for blood, perhaps due to contamination from oral bacteria, different cell compositions, or distinct methylation dynamics in epithelial versus immune cells. However, the interchangeability of buffy coat and PBMCs—both blood-derived immune cells—is encouraging for standardization. The observation that newer clocks show better tissue consistency hints that algorithm design (rather than biology alone) influences cross-tissue comparability.
This remains preliminary work requiring replication in larger, more diverse, and older populations before recommending clinical practice changes. The practical takeaway: if researchers or clinicians implement epigenetic clocks, tissue type must be consistent within studies or analyses, and saliva-based aging estimates should not be directly compared to blood-based ones without validation.
0 Comments
Log in to join the discussion.